90 related articles for article (PubMed ID: 12823208)
1. Nuclear BAG-1 expression is a biomarker of poor prognosis in esophageal squamous cell carcinoma.
Noguchi T; Takeno S; Shibata T; Fumoto S; Uchida Y; Yokoyama S; Gabbert HE; Müller W
Dis Esophagus; 2003; 16(2):107-11. PubMed ID: 12823208
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
3. Nuclear, cytoplasmic, and stromal expression of ZEB1 in squamous and small cell carcinoma of the esophagus.
Goscinski MA; Xu R; Zhou F; Wang J; Yang H; Huang R; Li Y; Larsen SG; Giercksky KE; Nesland JM; Suo Z
APMIS; 2015 Dec; 123(12):1040-7. PubMed ID: 26547370
[TBL] [Abstract][Full Text] [Related]
4. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis.
Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C
J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810
[TBL] [Abstract][Full Text] [Related]
5. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
[TBL] [Abstract][Full Text] [Related]
6. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
7. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma.
Tachibana M; Shibakita M; Ohno S; Kinugasa S; Yoshimura H; Ueda S; Fujii T; Rahman MA; Dhar DK; Nagasue N
Cancer; 2002 Apr; 94(7):1955-60. PubMed ID: 11932897
[TBL] [Abstract][Full Text] [Related]
9. NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma.
Chen GQ; Tian H; Yue WM; Li L; Li SH; Qi L; Gao C; Si LB; Lu M
Med Oncol; 2014 Dec; 31(12):376. PubMed ID: 25416054
[TBL] [Abstract][Full Text] [Related]
10. XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.
Shiozaki A; Kosuga T; Ichikawa D; Komatsu S; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Shimizu H; Ishimoto T; Kitagawa M; Nakou Y; Kishimoto M; Liu M; Otsuji E
Ann Surg Oncol; 2013 Sep; 20(9):3140-50. PubMed ID: 22805860
[TBL] [Abstract][Full Text] [Related]
11. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
[TBL] [Abstract][Full Text] [Related]
12. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
14. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
[TBL] [Abstract][Full Text] [Related]
16. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
[TBL] [Abstract][Full Text] [Related]
17. h-Prune is an independent prognostic marker for survival in esophageal squamous cell carcinoma.
Noguchi T; Oue N; Wada S; Sentani K; Sakamoto N; Kikuchi A; Yasui W
Ann Surg Oncol; 2009 May; 16(5):1390-6. PubMed ID: 17896143
[TBL] [Abstract][Full Text] [Related]
18. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Li TY; Xu LY; Wu ZY; Liao LD; Shen JH; Xu XE; Du ZP; Zhao Q; Li EM
Hum Pathol; 2012 Jul; 43(7):1068-76. PubMed ID: 22204712
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma.
Wang Z; He W; Yang G; Wang J; Wang Z; Nesland JM; Holm R; Suo Z
BMC Cancer; 2010 Jul; 10():352. PubMed ID: 20602752
[TBL] [Abstract][Full Text] [Related]
20. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
